ARTICLES

Explore published articles and webinars from Litmys leaders that spotlight new thinking and practical approaches to achieving market success across the life sciences.

Man in blue shirt and jeans faces wall with tangled, dashed lines and question marks, pondering life sciences regulatory uncertainty

Regulatory Uncertainty in Life Sciences Is Increasing the Risk of Innovation

Innovation in life sciences has always involved uncertainty. Today, however, regulatory unpredictability is becoming a growing driver of risk, influencing not only approval pathways but also real world confidence in new therapies.

Feb 181 min read

Rocket launch graphic symbolizing a pharmaceutical product launch driven by Phase III clinical strategy.

Managing Partner, Harris Kaplan, published in PharmExec: Your Phase III Clinical Protocol Is Your Initial Product Launch

Phase III clinical protocols do more than satisfy regulators. They determine what a product can claim, how it will be valued, and whether it can truly compete at launch.

Jan 301 min read

Webinar on Demand: Why the Battle for Future Market Share is Increasingly Won Before Phase 3

Most products that stumble post-approval don’t fail on efficacy; they fail because they weren’t built with the market in mind. Our recent webinar, Why the Battle for Future Market Share is Increasingly Won Before Phase 3, brought together experts from across biotech, investment, clinical, and pharma to discuss how to design for adoption, not just approval.

Sep 29, 20251 min read

Silver spinning top with glowing light flare on smooth, dark surface.

Managing Partner, Harris Kaplan, published in In Vivo: Physician Behavioral Inertia - Innovation’s Greatest Enemy

Harris Kaplan , Managing Partner, just published an article in In Vivo, Physician Behavioral Inertia: Innovation’s Greatest Enemy ....

Sep 26, 20231 min read

A beaker with blue liquid and a pipette. Background features blurred numbers and graphs, creating a scientific and analytical atmosphere.

Managing Partner, Harris Kaplan, published in Forbes: Biotech Investing - Is Hope Fueling Hype?

Harris Kaplan , Managing Partner, just published an article in Forbes, Biotech Investing: Is Hope Fueling Hype? . Hope is a major reason...

Oct 28, 20211 min read

A scale balancing "REALISM" and "OPTIMISM" spheres, with a needle centered. Text: "Biotech Investment Opportunities." Gray backdrop.

Managing Partner, Harris Kaplan, published in Forbes: The Importance Of Being An Optimistic Realist In Biotech Investing

Harris Kaplan , Managing Partner, just published an article in Forbes, The Importance Of Being An Optimistic Realist In Biotech...

Jul 13, 20211 min read

Silhouette of a head with a blue maze pattern, red glow in the center, on a textured gray background, symbolizing complexity or thought.

Managing Partner, Harris Kaplan, published in PM360: Into the Mind of the Payer

Harris Kaplan , Managing Partner, just published an article on PM360, Into the Mind of the Payer . Harris has interviewed countless...

Apr 26, 20211 min read

Golden coins overlay a cityscape with financial graphs, creating a theme of economic growth. Predominant colors are gold and yellow.

Managing Partner, Harris Kaplan, published in Forbes: All That Glitters Isn't Gold: Questions To Ask

Harris Kaplan , Managing Partner, just published an article in Forbes, All That Glitters Isn't Gold: Questions To Ask Yourself Before...

Mar 10, 20211 min read

Pyramid diagram of Maslow's Hierarchy: Food, Security, Social needs, Accomplishment, Potential. Arrow labeled Immediate Importance points up.

Managing Partner, Harris Kaplan, published in PharmExec: Marketers - Physicians are People First

Harris Kaplan , Managing Partner, just published an article in PharmExec (titled Marketers: Physicians are People First ) that looks at...

Nov 17, 20201 min read

Join us for Informa’s Newest Webinar – Transforming Cancer Treatment with Early Detection Diagnostics: Opportunities and Obstacles

We are pleased to announce that on October 22, Managing Partner, Harris Kaplan , will be joined by experts in the oncology field, where...

Oct 1, 20201 min read

Virtual Health Care: Where Does This Leave Pharma Marketing?

Managing partner, Harris Kaplan , participated in Pharma intelligence ‘s 24-hour web event on COVID-19: Lessons Learned and a Path...

Sep 1, 20201 min read

Join us for Informa’s 24-Hour Web Event – COVID-19: Lesson Learned and a Path Forward

We are pleased to announce that Harris Kaplan , Managing Partner, will be participating in a new 24-hour web event , hosted by Informa...

Jul 1, 20201 min read

Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Harris Kaplan , Managing Partner, has partnered with Fred Dotzler to write the cover story for In Vivo January 2019. The article delves into what payers are doing in today’s world to try to control the cost of new life science products, and what steps they plan on taking to better control rising costs in the future. Payer Power: What Are The Future Implications For Life Science Companies Developing New Products?

Jan 16, 20191 min read

Mail